ATE353017T1 - Herstellung von impstoffen zür vorbeugung von pathogenen zuständen einer hiv retroviraler infektion - Google Patents

Herstellung von impstoffen zür vorbeugung von pathogenen zuständen einer hiv retroviraler infektion

Info

Publication number: ATE353017T1
Authority: AT; Austria
Prior art keywords: vaccines; production; retroviral infection; pathogenic conditions; prevent pathogenic
Prior art date: 1997-11-17

Application number

AT98955673T

Other languages

English (en)

Inventor

Pierre-Francois Serres

Christophe Geourjon

Gilbert Deleage

Christophe Combet

Original Assignee

Mymetics Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-11-17

Filing date

1998-11-17

Publication date

2007-02-15

1998-11-17 Application filed by Mymetics Sa filed Critical Mymetics Sa

2007-02-15 Application granted granted Critical

2007-02-15 Publication of ATE353017T1 publication Critical patent/ATE353017T1/de

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—RNA viruses
- C07K16/112—Retroviridae (F), e.g. leukemia viruses
- C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
- C07K16/1145—Env proteins, e.g. gp41, gp110/120, gp160, V3, principal neutralising domain [PND] or CD4-binding site
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
- C07K16/246—IL-2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Virology (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Immunology (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Epidemiology (AREA)
Microbiology (AREA)
Communicable Diseases (AREA)
Mycology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Hematology (AREA)
Gastroenterology & Hepatology (AREA)
Oncology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Tropical Medicine & Parasitology (AREA)
AIDS & HIV (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)

AT98955673T 1997-11-17 1998-11-17 Herstellung von impstoffen zür vorbeugung von pathogenen zuständen einer hiv retroviraler infektion ATE353017T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9714387A FR2771011B1 (fr)	1997-11-17	1997-11-17	Obtention de vaccins destines a prevenir les effets pathogenes associes a une infection retrovirale

Publications (1)

Publication Number	Publication Date
ATE353017T1 true ATE353017T1 (de)	2007-02-15

Family

ID=9513450

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT98955673T ATE353017T1 (de)	1997-11-17	1998-11-17	Herstellung von impstoffen zür vorbeugung von pathogenen zuständen einer hiv retroviraler infektion

Country Status (19)

Country	Link
US (3)	US6455265B1 (de)
EP (1)	EP1034000B1 (de)
JP (1)	JP4837823B2 (de)
KR (1)	KR20010032210A (de)
CN (1)	CN1281371A (de)
AP (1)	AP2000001841A0 (de)
AT (1)	ATE353017T1 (de)
AU (1)	AU1243499A (de)
BR (1)	BR9814204A (de)
CA (1)	CA2309676C (de)
DE (1)	DE69837012T2 (de)
DK (1)	DK1034000T3 (de)
EA (1)	EA200000528A1 (de)
ES (1)	ES2281938T3 (de)
FR (1)	FR2771011B1 (de)
IL (2)	IL136163A0 (de)
OA (1)	OA11522A (de)
PT (1)	PT1034000E (de)
WO (1)	WO1999025377A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2771011B1 (fr) *	1997-11-17	2000-01-28	Hippocampe	Obtention de vaccins destines a prevenir les effets pathogenes associes a une infection retrovirale
CN1396178A (zh) *	2002-06-17	2003-02-12	成都阳辉生物科技有限责任公司	抗乙肝病毒等包膜病毒感染的工程多肽及其制备方法
EP1466924B9 (de) *	2003-04-11	2013-06-19	Institut Pasteur	Synthetische Peptid-HIV-Vakzine: das CBD-Epitop als effizientes Immunogen zur Induktion HIV-neutralisierender Antikörper
CN1860130B (zh)	2003-07-30	2012-05-30	迈梅蒂克斯公司	新的可溶且稳定的三聚体形式的gp41多肽
JP2007505320A (ja) *	2003-09-11	2007-03-08	アイデックスラボラトリーズインコーポレイテッド	ネコ免疫不全ウイルスの検出のための方法と装置
US7285272B2 (en) *	2003-12-18	2007-10-23	Idexx Laboratories, Inc.	Method and device for detecting feline immunodeficiency virus
DE602005027326D1 (de) *	2004-02-19	2011-05-19	Idexx Lab Inc	Verfahren und vorrichtung zum nachweis von katzen-immunschwächevirus
CA2561376C (en) *	2004-03-30	2016-06-21	Institut Gustave Roussy	Polypeptide sequence involved in the modulation of the immunosuppresive effect of viral proteins
US20060003445A1 (en) *	2004-06-30	2006-01-05	Idexx Laboratories, Inc.	Method and device for detecting feline immunodeficiency virus
CA2576930C (en) *	2004-06-30	2011-06-07	Idexx Laboratories, Inc.	Method and device for detecting feline immunodeficiency virus (fiv) comprising the use of peptides derived from the v3 region of the fiv env protein
JP4307505B2 (ja) *	2004-06-30	2009-08-05	アイデックスラボラトリーズインコーポレイテッド	ネコ免疫不全ウイルスの検出のための方法と装置
US7291338B2 (en) *	2005-03-09	2007-11-06	Idexx Laboratories, Inc.	Method and device for detecting feline immunodeficiency virus
WO2006117586A1 (en) *	2005-05-02	2006-11-09	Mymetics Corporation	Antibody or a fragment thereof, having neutralizing activity against hiv but not against il2
TWI343180B (en) *	2005-07-01	2011-06-01	Ind Tech Res Inst	The acoustic wave sensing-device integrated with micro channels
WO2007099387A1 (en) *	2006-03-03	2007-09-07	Mymetics Corporation	Virosome-like vesicles comprising gp41-derived antigens
CN1869704B (zh) *	2006-06-14	2010-06-30	厦门大学	快速鉴定与病原菌互作的宿主蛋白的方法
US20110195089A1 (en) *	2008-10-08	2011-08-11	The Adminstrators Of The Tulane Educational Fund	Compositions, methods, and kits for enhancing the immunogenicity of pathogenic antigens
AP3402A (en)	2009-02-06	2015-08-31	Mymetics Corp	Splitting GP41
WO2010089400A1 (en)	2009-02-06	2010-08-12	Mymetics Corporation	Novel gp41 antigens
EP2467163A2 (de) *	2009-08-21	2012-06-27	Dana-Farber Cancer Institute, Inc.	Mimotope von hiv und anwendungen davon
US8809004B2 (en)	2010-04-02	2014-08-19	Idexx Laboratories, Inc.	Detection of feline immunodeficiency virus
CA2832109C (en)	2011-06-10	2021-07-06	Oregon Health & Science University	Cmv glycoproteins and recombinant vectors
AU2013308623B2 (en)	2012-08-30	2017-03-02	Merial, Inc.	Hyperbaric device and methods for producing inactivated vaccines and for refolding/solubilizing recombinant proteins
US20220065857A1 (en) *	2018-12-12	2022-03-03	The Johns Hopkins University	Hiv serosignatures for cross-sectional incidence estimation
WO2021185851A1 (en)	2020-03-17	2021-09-23	INSERM (Institut National de la Santé et de la Recherche Médicale)	Vaccine compositions for hiv prevention and treatment
CN111701016A (zh) *	2020-06-28	2020-09-25	张全志	逆转录病毒原病毒序列在逆转录病毒疫苗设计中的应用
CN118515733B (zh) *	2023-02-20	2025-11-18	菲鹏生物股份有限公司	Hiv蛋白及其在检测hiv抗体中的应用
CN118561966B (zh) *	2024-05-20	2025-07-11	浙江大学	人内源性逆转录病毒包膜蛋白突变体、截短体及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1993001304A1 (en) *	1991-07-10	1993-01-21	Synbiotics Corporation	Synthetic peptides related to fiv-env proteins
DE69326069T2 (de) *	1992-07-20	2000-03-23	Duke University, Durham	Zusammensetzungen die die hiv replikation inhibieren
GB9219936D0 (en) *	1992-09-21	1992-11-04	Pitman Moore Inc	Vaccines
US6017536A (en) *	1993-06-07	2000-01-25	Trimeris, Inc.	Simian immunodeficiency virus peptides with antifusogenic and antiviral activities
US6479055B1 (en) *	1993-06-07	2002-11-12	Trimeris, Inc.	Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission
FR2771011B1 (fr) *	1997-11-17	2000-01-28	Hippocampe	Obtention de vaccins destines a prevenir les effets pathogenes associes a une infection retrovirale

1997
- 1997-11-17 FR FR9714387A patent/FR2771011B1/fr not_active Expired - Fee Related
1998
- 1998-11-17 DK DK98955673T patent/DK1034000T3/da active
- 1998-11-17 EP EP98955673A patent/EP1034000B1/de not_active Expired - Lifetime
- 1998-11-17 OA OA1200000145A patent/OA11522A/fr unknown
- 1998-11-17 EA EA200000528A patent/EA200000528A1/ru unknown
- 1998-11-17 BR BR9814204-6A patent/BR9814204A/pt not_active IP Right Cessation
- 1998-11-17 AU AU12434/99A patent/AU1243499A/en not_active Abandoned
- 1998-11-17 KR KR1020007005402A patent/KR20010032210A/ko not_active Withdrawn
- 1998-11-17 PT PT98955673T patent/PT1034000E/pt unknown
- 1998-11-17 AP APAP/P/2000/001841A patent/AP2000001841A0/en unknown
- 1998-11-17 IL IL13616398A patent/IL136163A0/xx active IP Right Grant
- 1998-11-17 ES ES98955673T patent/ES2281938T3/es not_active Expired - Lifetime
- 1998-11-17 WO PCT/FR1998/002447 patent/WO1999025377A1/fr not_active Ceased
- 1998-11-17 JP JP2000520810A patent/JP4837823B2/ja not_active Expired - Fee Related
- 1998-11-17 DE DE69837012T patent/DE69837012T2/de not_active Expired - Lifetime
- 1998-11-17 CA CA2309676A patent/CA2309676C/fr not_active Expired - Fee Related
- 1998-11-17 AT AT98955673T patent/ATE353017T1/de active
- 1998-11-17 CN CN98811909A patent/CN1281371A/zh active Pending
2000
- 2000-05-15 US US09/570,921 patent/US6455265B1/en not_active Expired - Lifetime
- 2000-05-16 IL IL136163A patent/IL136163A/en not_active IP Right Cessation
2002
- 2002-07-22 US US10/198,938 patent/US7253270B2/en not_active Expired - Fee Related
2007
- 2007-07-16 US US11/826,471 patent/US7829683B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
OA11522A (fr)	2004-02-09
CN1281371A (zh)	2001-01-24
ES2281938T3 (es)	2007-10-01
EP1034000B1 (de)	2007-01-31
WO1999025377A1 (fr)	1999-05-27
DE69837012D1 (de)	2007-03-22
US7829683B2 (en)	2010-11-09
US20080003229A1 (en)	2008-01-03
EA200000528A1 (ru)	2001-02-26
US7253270B2 (en)	2007-08-07
JP2001524456A (ja)	2001-12-04
CA2309676A1 (fr)	1999-05-27
IL136163A (en)	2007-07-04
JP4837823B2 (ja)	2011-12-14
KR20010032210A (ko)	2001-04-16
DE69837012T2 (de)	2007-11-29
FR2771011B1 (fr)	2000-01-28
AP2000001841A0 (en)	2000-06-30
BR9814204A (pt)	2000-10-03
EP1034000A1 (de)	2000-09-13
FR2771011A1 (fr)	1999-05-21
PT1034000E (pt)	2007-05-31
US20050048478A9 (en)	2005-03-03
DK1034000T3 (da)	2007-06-04
US6455265B1 (en)	2002-09-24
US20040014046A1 (en)	2004-01-22
AU1243499A (en)	1999-06-07
CA2309676C (fr)	2012-08-07
IL136163A0 (en)	2001-05-20

Legal Events

Date

Code

Title

Description

2007-08-15

UEP

Publication of translation of european patent specification

Ref document number: 1034000

Country of ref document: EP

Publication	Publication Date	Title
ATE353017T1 (de)	2007-02-15	Herstellung von impstoffen zür vorbeugung von pathogenen zuständen einer hiv retroviraler infektion
DE69408679D1 (de)	1998-04-02	Herstellung von geformten faserstrukturen
DE3780933D1 (de)	1992-09-10	Herstellung von aminoalanen.
DE69121788D1 (de)	1996-10-10	Herstellung von Aluminoxanen
DE69008155D1 (de)	1994-05-19	Herstellung von Stoffliesen.
DE69117356D1 (de)	1996-04-04	Herstellung von Aluminoxanen
DE69531834D1 (de)	2003-10-30	Herstellung einer aerosolformulierung von insulin
ATE131185T1 (de)	1995-12-15	Herstellung von peroxidhaltigen perfluorpolyethern.
DE60038817D1 (de)	2008-06-19	Herstellung von cordieritstrukturen mit ultradünnen wänden
DE69812901D1 (de)	2003-05-08	Katalytische herstellung von pentafluorpropenen
DE3686547D1 (de)	1992-10-01	Herstellung von harnstoff-polyaminharzen fuer papierbekleidungszusammensetzungen.
DE60019960D1 (de)	2005-06-09	Herstellung von isobutencopolymere
DE69116826D1 (de)	1996-03-14	Herstellung von Alkoxyalkansäuren
DE69503632D1 (de)	1998-08-27	Herstellung von enthydroxylierten träger
DE69410266D1 (de)	1998-06-18	Herstellung von dimethyl cyclohexandicarboxylaten
FI871982A7 (fi)	1987-11-07	Foerfarande foer paovisning av aids-virusinfektion.
DE3688937D1 (de)	1993-09-30	Herstellung optisch aktiver aryloxypropanolamine und arylaethanolamine.
DE3766559D1 (de)	1991-01-17	Herstellung von kristallinem tribromstyrol.
FI913817A7 (fi)	1992-02-14	HIV:tä neutraloivan päädeterminantin uusia suoritusmuotoja
DE3778134D1 (de)	1992-05-14	Kontinuierliche herstellung von dialkansulfonylperoxiden.
DE69213862D1 (de)	1996-10-24	Herstellung von Aluminoxanen
DE3689971D1 (de)	1994-08-18	Herstellung einer halbleiteranordnung.
DE69506006D1 (de)	1998-12-17	Herstellung von keramischen gegenständen
DE3584300D1 (de)	1991-11-14	Herstellung von malaria-impfstoffen.
DE3752115D1 (de)	1997-10-23	Herstellung einer Dioxazinverbindung